Symbol Lookup

Wednesday November 25, 2015 3:16 PM ET. Data delayed 15 minutes.
3.16 (0.79%)
Open/Prev Close
Day Range
52-Week Range
Vol/Avg Daily Vol
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
Atrion Corporation Declares Quarterly Cash Dividend
12:11PM ET on Friday Nov 13, 2015 by Marketwire

Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly cash dividend of $0.90 per share on the Company's outstanding Common Stock. This dividend will be payable on December 15, 2015 to stockholders of...

Atrion Reports Third Quarter Results
5:19PM ET on Thursday Nov 05, 2015 by Marketwire

Atrion Corporation (NASDAQ: ATRI) today announced that for the third quarter of 2015 revenues totaled $37.4 million compared with $36.6 million for the same period in 2014. Operating income for the just-ended quarter was $11.6 million compared ...

Company Information

Atrion Corporation (Atrion) develops and manufactures products primarily for medical applications. The Company's medical products range from fluid delivery devices to ophthalmic and cardiovascular products. The Company's fluid delivery products include valves that promote infection control and needle safety. The Company has developed a variety of luer syringe check valves and one-way valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, catheter and other applications. The Company also makes tubing clamps in a variety of materials and colors that are compatible with various grades of tubing and sterilization processes and produce specialized intravenous sets for use in numerous applications, including anesthesia and oncology. The Company's principal cardiovascular product is the Myocardial Protection System (MPS2), a technology that delivers essential fluids and medications to the heart during open-heart surgery.


Headquarters1 Allentown Pkwy
ALLEN, TX, United States 75002-4206


Chairman of the BoardEmile Battat
President, Chief Executive OfficerDavid Battat
Chief Financial Officer, Vice President, Treasurer, SecretaryJeffery Strickland
Lead Independent DirectorRoger Stebbing
Independent DirectorHugh Morgan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$727.3MBeta0.59
Revenue (TTM)$146.1MEPS$15.28
Shares Out.1.8MBook Value$78.19
Dividend Yield0.90%P/E26.1x
Annual Dividend Rate3.60 USDPrice/Sales (TTM)5.0
Ex-Div Date11/27/15P/Cash Flow (TTM)19.3x
Pay Date12/15/15Operating Margin29.31%

*GAAP = prior to non-GAAP analyst adjusted earnings.


Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample